00898.TW Cathay Genomics Immunology Revolution ETF

- TWD
No recent price
Total assets
1.27B
Expense ratio
-
Dividend yield
-
1-year return
+51.53%
Holdings
10
Since
2021

Fund data as reported by the issuer, updated Nov 8, 2026. Total assets are in the fund's base currency.

What does 00898.TW invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (90.8%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (83.4%)
  • Top 3 holdings: 17.5% of the fund

Asset allocation

  • US stocks 90.8%
  • Non-US stocks 13.3%
  • Cash 4.4%

Top holdings

  • Iovance Biotherapeutics Inc 7.41%
  • Twist Bioscience Corp 5.08%
  • Genscript Biotech Corp 5.06%
  • 10X Genomics Inc 4.61%
  • Natera Inc 4.36%
All holdings, sectors and regions

Cathay Genomics Immunology Revolution ETF performance

Sharpe ratio 0.87
This year
+40.55%
1 year
+51.53%
3 years
+18.50%
5 years
-

Volatility 21.6% over 1 year and 21.7% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

00898.TW price

Prices on the chart can differ slightly from the closing prices StockSummer shows.